Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2010
06/02/2010EP2190848A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
06/02/2010EP2190847A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands
06/02/2010EP2190846A1 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands
06/02/2010EP2190837A1 4-pyrimidinesulfamide derivative
06/02/2010EP2190833A1 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
06/02/2010EP2190824A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
06/02/2010EP2190817A1 3-azabicyclo (4.1.0) heptane derivatives useful as norepinephrine, serotonin or dopamine reuptake inhibitors
06/02/2010EP2190815A1 Pyrrolidine aryl-ether as nk3 receptor antagonists
06/02/2010EP2190810A1 Compounds isolated from antrodia cinnamomea and use thereof
06/02/2010EP2190534A1 Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
06/02/2010EP2190465A2 Use of a peptide as a therapeutic agent
06/02/2010EP2190464A2 Use of leptin(22-56) as a therapeutic agent
06/02/2010EP2190463A2 Use of thymopentin as a therapeutic agent
06/02/2010EP2190459A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent
06/02/2010EP2190456A2 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
06/02/2010EP2190453A2 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents
06/02/2010EP2190452A2 Use of a peptide as a therapeutic agent
06/02/2010EP2190450A2 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
06/02/2010EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent
06/02/2010EP2190435A2 Treatment of sleep disorders
06/02/2010EP2190432A2 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors
06/02/2010EP2190427A1 Use of tocopherol derivatives as inhibitors of the notch signalling pathway
06/02/2010EP2059521B1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
06/02/2010EP2049532B1 Cgrp receptor antagonists
06/02/2010EP1833811B1 Oxygen containing heterocycles as glycine transporter inhibiting compounds
06/02/2010EP1773772B1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
06/02/2010EP1745040B9 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
06/02/2010EP1483228B1 Nk1 antagonists
06/02/2010EP1225174B2 Anhydrous mirtazapine crystals and process for the production thereof
06/02/2010DE102008059155A1 Trockenverarbeitung und neue Formen von Lacosamid Dry processing and new forms of lacosamide
06/02/2010CN201492164U Novel cushion
06/02/2010CN1994451B Chinese medicinal composition for treating depression, its preparation method and application
06/02/2010CN1938042B Use of aromatic cation peptide in preparing medicine for relieving oxidative damage
06/02/2010CN1826336B Cyclohexanecarboxylic acid compound
06/02/2010CN1809559B Pyrazole derivatives as phosphodiesterase 4 inhibitors
06/02/2010CN1354755B Nucleotide and protein sequence of Nogo genes and methods based thereon
06/02/2010CN101717439A Venin-derived cytotoxin CTXn for drug rehabilitation and purification method and application thereof
06/02/2010CN101717416A Derivative of alpha-amino phosphonic acid containing saccharide groups, preparation method and medical application thereof
06/02/2010CN101717410A Phosphorus-containing compounds & uses thereof
06/02/2010CN101716338A DNA vaccine for promoting regeneration and functional rehabilitation of nerves of central system
06/02/2010CN101716325A Compounded traditional Chinese medicine for treating chiral and pedal numbness
06/02/2010CN101716322A Traditional Chinese medicine composition for treating heart-blood deficiency disease and preparation method thereof
06/02/2010CN101716320A Externally applied medical composition for treating orthopedic diseases and preparation method thereof
06/02/2010CN101716310A Medicament for treating neuronal damage diseases and preparation method
06/02/2010CN101716303A Traditional Chinese medicine composition for treating heart-deficiency timidity disease and preparation method thereof
06/02/2010CN101716288A Traditional Chinese medicine preparation for treating postconcussion syndrome
06/02/2010CN101716285A Traditional Chinese medicine for treating rheumatic chorea
06/02/2010CN101716279A Instant traditional Chinese medicine for refreshing spirit, nourishing Qi and building body
06/02/2010CN101716262A Extract from Iris tenuifolia, preparation method and application thereof
06/02/2010CN101716247A Pulvis rhei traditional Chinese medicine compound preparation, preparation method and application thereof
06/02/2010CN101716240A Preparation for improving sleep, replenishing qi and promoting blood generation
06/02/2010CN101716222A Anti-alcohol vinegar and preparation method thereof
06/02/2010CN101716220A Shielding alkaloid traditional Chinese medicine
06/02/2010CN101716213A Traditional Chinese medicine effective fraction composition for detoxification and lipid lowering and preparation method thereof
06/02/2010CN101716206A Wild ginseng granules and preparation method thereof
06/02/2010CN101716204A Anticancer analgesic preparation and preparation method thereof
06/02/2010CN101716202A Traditional Chinese medicine containing radix achyranthis bidentatae for treating facioplegia as well as preparation method and use
06/02/2010CN101716170A Application of procyanidin in preparing drug for treating depression
06/02/2010CN101716168A Medicinal composition containing salt of desmethylvenlafaxine and method for preparing same
06/02/2010CN101716164A Nicergoline nasal powder and preparation method thereof
06/02/2010CN101716152A Flunarizine hydrochloride pills and preparation method thereof
06/02/2010CN101716149A New precursor medicinal preparation
06/02/2010CN101361708B Morphine sulphate suppository and preparation method thereof
06/02/2010CN101305975B Health preservation feet bath bag
06/02/2010CN101204575B Chinese traditional medicine composite for depressive neurosis, preparation method and application thereof
06/02/2010CN101204550B Medicine for epilepsy
06/02/2010CN101181614B Medicament for curing podosoma numbness caused by cerebrovascular disease
06/02/2010CN101181577B Lavender strip containing natural aromatic plant
06/02/2010CN101167999B Hot compress exergy and preparation method thereof
06/02/2010CN101151975B Pastry with help for sleep and production technique of the same
06/02/2010CN101130055B Method for producing medicament for treating headache
06/02/2010CN101085237B Internal-applied traditional Chinese medicine composition for treating neurasthenia
06/02/2010CN101035761B 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt
06/01/2010US7728037 Alpha-ketoglutarates of active ingredients and compositions containing same
06/01/2010US7728028 Substituted imidazoline compounds
06/01/2010US7728025 Glucokinase activators as antidiabetic, antiobesity agents; 5-(4-methanesulfonyl-phenoxy)-2-pyrazin-2-yl-6-(2-carbamoyl-phenoxy)-1H-benzimidazole for example
06/01/2010US7728016 Substituted 5-membered ring compounds and their use
06/01/2010US7727999 substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds, used as selective serotonin receptor antagonists, used rfor the treatment of schizophrenia, psychosis, headaches, hypertension, thrombosis, vasospasm, depression, anxiety, sleep disorders and appetite disorders
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727994 administering adenosine receptor antagonist; side effect reduction; Parkinson's disease
06/01/2010US7727993 administering adenosine receptor antagonist with dopamine antagonist;; Parkinson's disease; side effect reduction; low dosage of dopamine
06/01/2010US7727987 useful as intermediates for the preparation of stable polymorphic form B or are suitable for solid formulations; for treatment of neurological disorders such as parkinsonism and atypical phenylketonuria
06/01/2010US7727965 C-glycosylisoflavones having alkylaminoalkoxyl substituent, preparation and use of the same
06/01/2010US7727957 Treatment and delay of outset of Parkinson's disease
06/01/2010US7727952 Methods for treating spinal and bulbar muscular atrophy using LHRH analogs
06/01/2010US7727527 Anti-NGF antibodies for the therapeutic treatments
06/01/2010US7727519 Method for treating hepatitis C virus with omega interferon
06/01/2010CA2543640C Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action
06/01/2010CA2515841C Novel 2-pyridine carboxamide derivatives
06/01/2010CA2490120C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
06/01/2010CA2457965C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/01/2010CA2443456C Novel atisane compounds and use thereof
06/01/2010CA2427030C Fatigue recovering or fatigue preventive agent for central nervous system and food for fatigue recovery or fatigue prevention
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2400626C Estrogen receptor modulators
06/01/2010CA2374958C Compositions normalizing circadian rhythm
06/01/2010CA2366750C (e)-styryl sulfone anticancer agents
06/01/2010CA2361552C Drug for alleviating migraine
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 1833